221 related articles for article (PubMed ID: 35556229)
21. A Novel SS18-SSX Fusion-specific Antibody for the Diagnosis of Synovial Sarcoma.
Baranov E; McBride MJ; Bellizzi AM; Ligon AH; Fletcher CDM; Kadoch C; Hornick JL
Am J Surg Pathol; 2020 Jul; 44(7):922-933. PubMed ID: 32141887
[TBL] [Abstract][Full Text] [Related]
22. When used together SS18-SSX fusion-specific and SSX C-terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most cases.
Zaborowski M; Vargas AC; Pulvers J; Clarkson A; de Guzman D; Sioson L; Maclean F; Chou A; Gill AJ
Histopathology; 2020 Oct; 77(4):588-600. PubMed ID: 32559341
[TBL] [Abstract][Full Text] [Related]
23. Phase transition and remodeling complex assembly are important for SS18-SSX oncogenic activity in synovial sarcomas.
Cheng Y; Shen Z; Gao Y; Chen F; Xu H; Mo Q; Chu X; Peng CL; McKenzie TT; Palacios BE; Hu J; Zhou H; Long J
Nat Commun; 2022 May; 13(1):2724. PubMed ID: 35585082
[TBL] [Abstract][Full Text] [Related]
24. Synovial Sarcoma: A Complex Disease with Multifaceted Signaling and Epigenetic Landscapes.
El Beaino M; Rassy E; Hadid B; Araujo DM; Pavlidis N; Lin PP
Curr Oncol Rep; 2020 Oct; 22(12):124. PubMed ID: 33025259
[TBL] [Abstract][Full Text] [Related]
25. Histone deacetylase inhibitors reverse SS18-SSX-mediated polycomb silencing of the tumor suppressor early growth response 1 in synovial sarcoma.
Lubieniecka JM; de Bruijn DR; Su L; van Dijk AH; Subramanian S; van de Rijn M; Poulin N; van Kessel AG; Nielsen TO
Cancer Res; 2008 Jun; 68(11):4303-10. PubMed ID: 18519690
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of SS18-SSX1 expression in synovial sarcoma by small interfering RNA enhances the focal adhesion pathway and inhibits anchorage-independent growth in vitro and tumor growth in vivo.
Takenaka S; Naka N; Araki N; Hashimoto N; Ueda T; Yoshioka K; Yoshikawa H; Itoh K
Int J Oncol; 2010 Apr; 36(4):823-31. PubMed ID: 20198325
[TBL] [Abstract][Full Text] [Related]
27. Correlating SS18-SSX immunohistochemistry (IHC) with SS18 fluorescent in situ hybridization (FISH) in synovial sarcomas: a study of 36 cases.
Tay TKY; Sukma NB; Lim TH; Kuick CH; Goh JY; Chang KTE
Virchows Arch; 2021 Oct; 479(4):785-793. PubMed ID: 34091760
[TBL] [Abstract][Full Text] [Related]
28. SS18-SSX Expression in a Contemporary Cohort of Primary Renal Synovial Sarcoma: A Multi-Institutional Experience of Fourteen Patients.
Challa B; Mohanty SK; Jha S; Sampat NY; Sardana R; Lobo A; Sharma S; Arora S; Rath D; Munjal G; Pattnaik N; Jain D; Jain E; Dewan A; Dixit M; Malik V; Shinde S; Balzer BL; Parwani A
Int J Surg Pathol; 2023 Oct; 31(7):1232-1243. PubMed ID: 36591871
[TBL] [Abstract][Full Text] [Related]
29. Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma.
Peng C; Zhao H; Chen W; Song Y; Wang X; Li J; Qiao Y; Wu D; Ma S; Wang X; Gao C
Oncotarget; 2016 Oct; 7(41):66822-66834. PubMed ID: 27572315
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of SS18-SSX1 expression by small interfering RNA inhibits growth and induces apoptosis in human synovial sarcoma cell line HS-SY-II in vitro.
Peng C; Guo W; Yang Y; Zhao H
Eur J Cancer Prev; 2008 Oct; 17(5):392-8. PubMed ID: 18714179
[TBL] [Abstract][Full Text] [Related]
31. Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma.
Brien GL; Remillard D; Shi J; Hemming ML; Chabon J; Wynne K; Dillon ET; Cagney G; Van Mierlo G; Baltissen MP; Vermeulen M; Qi J; Fröhling S; Gray NS; Bradner JE; Vakoc CR; Armstrong SA
Elife; 2018 Nov; 7():. PubMed ID: 30431433
[TBL] [Abstract][Full Text] [Related]
32. The clinical implication of SS18-SSX fusion gene in synovial sarcoma.
Ren T; Lu Q; Guo W; Lou Z; Peng X; Jiao G; Sun Y
Br J Cancer; 2013 Oct; 109(8):2279-85. PubMed ID: 24022186
[TBL] [Abstract][Full Text] [Related]
33. The C terminus of the synovial sarcoma-associated SSX proteins interacts with the LIM homeobox protein LHX4.
de Bruijn DR; van Dijk AH; Willemse MP; van Kessel AG
Oncogene; 2008 Jan; 27(5):653-62. PubMed ID: 17667940
[TBL] [Abstract][Full Text] [Related]
34. SS18-SSX-regulated miR-17 promotes tumor growth of synovial sarcoma by inhibiting p21WAF1/CIP1.
Minami Y; Kohsaka S; Tsuda M; Yachi K; Hatori N; Tanino M; Kimura T; Nishihara H; Minami A; Iwasaki N; Tanaka S
Cancer Sci; 2014 Sep; 105(9):1152-9. PubMed ID: 24989082
[TBL] [Abstract][Full Text] [Related]
35. Paracrine osteoprotegerin and β-catenin stabilization support synovial sarcomagenesis in periosteal cells.
Barrott JJ; Illum BE; Jin H; Hedberg ML; Wang Y; Grossmann A; Haldar M; Capecchi MR; Jones KB
J Clin Invest; 2018 Jan; 128(1):207-218. PubMed ID: 29202462
[TBL] [Abstract][Full Text] [Related]
36. Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
Kawano S; Grassian AR; Tsuda M; Knutson SK; Warholic NM; Kuznetsov G; Xu S; Xiao Y; Pollock RM; Smith JS; Kuntz KK; Ribich S; Minoshima Y; Matsui J; Copeland RA; Tanaka S; Keilhack H
PLoS One; 2016; 11(7):e0158888. PubMed ID: 27391784
[TBL] [Abstract][Full Text] [Related]
37. The synovial-sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation.
de Bruijn DR; Allander SV; van Dijk AH; Willemse MP; Thijssen J; van Groningen JJ; Meltzer PS; van Kessel AG
Cancer Res; 2006 Oct; 66(19):9474-82. PubMed ID: 17018603
[TBL] [Abstract][Full Text] [Related]
38. Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma.
Kadoch C; Crabtree GR
Cell; 2013 Mar; 153(1):71-85. PubMed ID: 23540691
[TBL] [Abstract][Full Text] [Related]
39. SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X;18)(p11.2;q11.2) translocation.
Xie Y; Skytting B; Nilsson G; Gasbarri A; Haslam K; Bartolazzi A; Brodin B; Mandahl N; Larsson O
Cancer Res; 2002 Jul; 62(13):3861-7. PubMed ID: 12097301
[TBL] [Abstract][Full Text] [Related]
40. Targeting the Wnt pathway in synovial sarcoma models.
Barham W; Frump AL; Sherrill TP; Garcia CB; Saito-Diaz K; VanSaun MN; Fingleton B; Gleaves L; Orton D; Capecchi MR; Blackwell TS; Lee E; Yull F; Eid JE
Cancer Discov; 2013 Nov; 3(11):1286-301. PubMed ID: 23921231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
